Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion

Skye Mayo, Andrew D. Shore, Hari Nathan, Barish H. Edil, Kenzo Hirose, Robert A. Anders, Christopher L. Wolfgang, Richard D. Schulick, Michael A. Choti, Timothy M. Pawlik

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Objectives: Defining perioperative mortality as death that occurs within 30 days of surgery may underestimate 'true' mortality among patients undergoing hepatic resection. To better define perioperative mortality, trends in the risk for death during the first 90 days after hepatectomy were assessed. Methods: Surveillance, Epidemiology and End Results (SEER) Medicare data were used to identify 2597 patients who underwent hepatic resection during 1991-2006. Data on their clinicopathological characteristics, surgical management and perioperative mortality were collected and survival was assessed at 30, 60 and 90 days post-surgery. Results: Overall, 5.7% of patients died within the first 30 days. Postoperative mortality at 60 and 90 days were 8.3% and 10.1%. In-hospital mortality after hepatic resection was greater among patients with hepatocellular carcinoma (HCC) than among those with colorectal liver metastases (CRLM) (8.9% and 3.8%, respectively; P <0.001). In CRLM patients, mortality increased from 4.3% at 30 days to 8.4% at 90 days, whereas mortality in HCC patients increased from 9.7% at 30 days to 15.0% at 90 days (both P <0.05). Patients with HCC were twice as likely as CRLM patients to die within 30 days [odds ratio (OR) 2.03], 60 days (OR = 1.74) and 90 days (OR = 1.71) (all P <0.001). Differences in 30- and 90-day mortality were greatest among HCC patients undergoing major hepatic resection (P <0.05). Conclusions: Reporting deaths that occur within a maximum of 30 days of surgery underestimates the mortality associated with hepatic resection. Traditional 30-day definitions of mortality are misleading and surgeons should report all perioperative outcomes that occur within 90 days of hepatic resection.

Original languageEnglish (US)
Pages (from-to)473-482
Number of pages10
JournalHPB
Volume13
Issue number7
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Hepatectomy
Mortality
Liver
Hepatocellular Carcinoma
Ambulatory Surgical Procedures
Odds Ratio
Neoplasm Metastasis
Medicare
Hospital Mortality
Epidemiology
Survival

Keywords

  • Epidemiology and End Results)
  • hepatectomy
  • Medicare
  • mortality
  • SEER (Surveillance
  • surgery
  • survival

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. / Mayo, Skye; Shore, Andrew D.; Nathan, Hari; Edil, Barish H.; Hirose, Kenzo; Anders, Robert A.; Wolfgang, Christopher L.; Schulick, Richard D.; Choti, Michael A.; Pawlik, Timothy M.

In: HPB, Vol. 13, No. 7, 07.2011, p. 473-482.

Research output: Contribution to journalArticle

Mayo, S, Shore, AD, Nathan, H, Edil, BH, Hirose, K, Anders, RA, Wolfgang, CL, Schulick, RD, Choti, MA & Pawlik, TM 2011, 'Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion', HPB, vol. 13, no. 7, pp. 473-482. https://doi.org/10.1111/j.1477-2574.2011.00326.x
Mayo, Skye ; Shore, Andrew D. ; Nathan, Hari ; Edil, Barish H. ; Hirose, Kenzo ; Anders, Robert A. ; Wolfgang, Christopher L. ; Schulick, Richard D. ; Choti, Michael A. ; Pawlik, Timothy M. / Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. In: HPB. 2011 ; Vol. 13, No. 7. pp. 473-482.
@article{8cf08b80afaf423b9a607fc5e892c739,
title = "Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion",
abstract = "Objectives: Defining perioperative mortality as death that occurs within 30 days of surgery may underestimate 'true' mortality among patients undergoing hepatic resection. To better define perioperative mortality, trends in the risk for death during the first 90 days after hepatectomy were assessed. Methods: Surveillance, Epidemiology and End Results (SEER) Medicare data were used to identify 2597 patients who underwent hepatic resection during 1991-2006. Data on their clinicopathological characteristics, surgical management and perioperative mortality were collected and survival was assessed at 30, 60 and 90 days post-surgery. Results: Overall, 5.7{\%} of patients died within the first 30 days. Postoperative mortality at 60 and 90 days were 8.3{\%} and 10.1{\%}. In-hospital mortality after hepatic resection was greater among patients with hepatocellular carcinoma (HCC) than among those with colorectal liver metastases (CRLM) (8.9{\%} and 3.8{\%}, respectively; P <0.001). In CRLM patients, mortality increased from 4.3{\%} at 30 days to 8.4{\%} at 90 days, whereas mortality in HCC patients increased from 9.7{\%} at 30 days to 15.0{\%} at 90 days (both P <0.05). Patients with HCC were twice as likely as CRLM patients to die within 30 days [odds ratio (OR) 2.03], 60 days (OR = 1.74) and 90 days (OR = 1.71) (all P <0.001). Differences in 30- and 90-day mortality were greatest among HCC patients undergoing major hepatic resection (P <0.05). Conclusions: Reporting deaths that occur within a maximum of 30 days of surgery underestimates the mortality associated with hepatic resection. Traditional 30-day definitions of mortality are misleading and surgeons should report all perioperative outcomes that occur within 90 days of hepatic resection.",
keywords = "Epidemiology and End Results), hepatectomy, Medicare, mortality, SEER (Surveillance, surgery, survival",
author = "Skye Mayo and Shore, {Andrew D.} and Hari Nathan and Edil, {Barish H.} and Kenzo Hirose and Anders, {Robert A.} and Wolfgang, {Christopher L.} and Schulick, {Richard D.} and Choti, {Michael A.} and Pawlik, {Timothy M.}",
year = "2011",
month = "7",
doi = "10.1111/j.1477-2574.2011.00326.x",
language = "English (US)",
volume = "13",
pages = "473--482",
journal = "HPB",
issn = "1365-182X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion

AU - Mayo, Skye

AU - Shore, Andrew D.

AU - Nathan, Hari

AU - Edil, Barish H.

AU - Hirose, Kenzo

AU - Anders, Robert A.

AU - Wolfgang, Christopher L.

AU - Schulick, Richard D.

AU - Choti, Michael A.

AU - Pawlik, Timothy M.

PY - 2011/7

Y1 - 2011/7

N2 - Objectives: Defining perioperative mortality as death that occurs within 30 days of surgery may underestimate 'true' mortality among patients undergoing hepatic resection. To better define perioperative mortality, trends in the risk for death during the first 90 days after hepatectomy were assessed. Methods: Surveillance, Epidemiology and End Results (SEER) Medicare data were used to identify 2597 patients who underwent hepatic resection during 1991-2006. Data on their clinicopathological characteristics, surgical management and perioperative mortality were collected and survival was assessed at 30, 60 and 90 days post-surgery. Results: Overall, 5.7% of patients died within the first 30 days. Postoperative mortality at 60 and 90 days were 8.3% and 10.1%. In-hospital mortality after hepatic resection was greater among patients with hepatocellular carcinoma (HCC) than among those with colorectal liver metastases (CRLM) (8.9% and 3.8%, respectively; P <0.001). In CRLM patients, mortality increased from 4.3% at 30 days to 8.4% at 90 days, whereas mortality in HCC patients increased from 9.7% at 30 days to 15.0% at 90 days (both P <0.05). Patients with HCC were twice as likely as CRLM patients to die within 30 days [odds ratio (OR) 2.03], 60 days (OR = 1.74) and 90 days (OR = 1.71) (all P <0.001). Differences in 30- and 90-day mortality were greatest among HCC patients undergoing major hepatic resection (P <0.05). Conclusions: Reporting deaths that occur within a maximum of 30 days of surgery underestimates the mortality associated with hepatic resection. Traditional 30-day definitions of mortality are misleading and surgeons should report all perioperative outcomes that occur within 90 days of hepatic resection.

AB - Objectives: Defining perioperative mortality as death that occurs within 30 days of surgery may underestimate 'true' mortality among patients undergoing hepatic resection. To better define perioperative mortality, trends in the risk for death during the first 90 days after hepatectomy were assessed. Methods: Surveillance, Epidemiology and End Results (SEER) Medicare data were used to identify 2597 patients who underwent hepatic resection during 1991-2006. Data on their clinicopathological characteristics, surgical management and perioperative mortality were collected and survival was assessed at 30, 60 and 90 days post-surgery. Results: Overall, 5.7% of patients died within the first 30 days. Postoperative mortality at 60 and 90 days were 8.3% and 10.1%. In-hospital mortality after hepatic resection was greater among patients with hepatocellular carcinoma (HCC) than among those with colorectal liver metastases (CRLM) (8.9% and 3.8%, respectively; P <0.001). In CRLM patients, mortality increased from 4.3% at 30 days to 8.4% at 90 days, whereas mortality in HCC patients increased from 9.7% at 30 days to 15.0% at 90 days (both P <0.05). Patients with HCC were twice as likely as CRLM patients to die within 30 days [odds ratio (OR) 2.03], 60 days (OR = 1.74) and 90 days (OR = 1.71) (all P <0.001). Differences in 30- and 90-day mortality were greatest among HCC patients undergoing major hepatic resection (P <0.05). Conclusions: Reporting deaths that occur within a maximum of 30 days of surgery underestimates the mortality associated with hepatic resection. Traditional 30-day definitions of mortality are misleading and surgeons should report all perioperative outcomes that occur within 90 days of hepatic resection.

KW - Epidemiology and End Results)

KW - hepatectomy

KW - Medicare

KW - mortality

KW - SEER (Surveillance

KW - surgery

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=79959628541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959628541&partnerID=8YFLogxK

U2 - 10.1111/j.1477-2574.2011.00326.x

DO - 10.1111/j.1477-2574.2011.00326.x

M3 - Article

C2 - 21689231

AN - SCOPUS:79959628541

VL - 13

SP - 473

EP - 482

JO - HPB

JF - HPB

SN - 1365-182X

IS - 7

ER -